✦ LIBER ✦

Cerebrolysin in Vascular Dementia: Improvement of Clinical Outcome in a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

✍ Scribed by Alla B. Guekht; Herbert Moessler; Philipp H. Novak; Evgenyi I. Gusev

Book ID: 116709316
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 497 KB
Volume: 20
Category: Article
ISSN: 1532-8511
DOI: 10.1016/j.jstrokecerebrovasdis.2010.01.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ginsenoside-Rd improves outcome of acute

Ginsenoside-Rd improves outcome of acute ischaemic stroke – a randomized, double-blind, placebo-controlled, multicenter trial

✍ X. Liu; L. Wang; A. Wen; J. Yang; Y. Yan; Y. Song; X. Liu; H. Ren; Y. Wu; Z. Li; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 670 KB

Intravenous propafenone in paroxysmal at

Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo-controlled, double-blind, multicenter clinical trial

✍ Claudio Fresco; Alessandro Proclemer; Alessandro Pavan; Gianfranco Buia; Alfredo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB

S-Adenosylmethionine in alcoholic liver

S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial

✍ Jose M Mato; Javier Cámara; Javier Fernández de Paz; Llorenç Caballería; Susana 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 1018 KB

Cerebrolysin in Alzheimer's disease: a r

Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent

✍ M. Panisset; S. Gauthier; H. Moessler; M. Windisch; and The Cerebrolysin Study G 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 103 KB

Gabapentin in the treatment of fibromyal

Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial

✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin

The mad-B study: A randomized, double-bl

The mad-B study: A randomized, double-blind, placebo-controlled trial with cerebrolysin in Alzheimer's disease

✍ Eckhart Ruether; Herbert Moessler; Manfred Windisch 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 200 KB